Antitrust Antitrust

Comment: Evolving US merger enforcement landscape suggests caution for dealmakers in 2022

The change in the US administration in 2021, which brought more aggressive enforcement and an effort to undertake significant merger reforms, suggests that companies should be more careful about regulatory risks in 2022.

The healthcare and technology industries are likely to continue to draw the attention of enforcers, who are also likely

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Flavia Fortes

Global Head of Mergers

Flavia writes about merger control, antitrust enforcement and litigation in the U.S. and Brazil. Before joining MLex, Flavia worked as an Antitrust Consultant in the Federal Trade Commission's Office of International Affairs and as a Research Fellow for the American Antitrust Institute. She has written on the intersection of antitrust law and intellectual property law in technology-driven and innovative markets.

Discover MLex

Stay on top of global regulatory developments


Latest News